MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance paves the way for healthcare providers and physicians in acute care settings to have access to this artificial intelligence (AI) software designed to aid in prioritizing the clinical assessment of adult non-contrast head computed tomography (CT) cases that exhibit indications of intracranial hemorrhage (ICH), commonly known as a brain bleed.

Here are a few of the radiation oncology technology advancement takeaways seen at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in October.

To see some of the newest technologies displayed on the expo floor, watch the VIDEO "Editor's Choice of the Most Innovative Radiation Oncology Tech at ASTRO 2018."

 

Dave Fornell, ITN Editor at ASTRO

Submitted by dfornell on Thu, 11/08/2018 - 07:19

Dave Fornell is the editor of Diagnostic & Interventional Cardiology magazine and assistant editor for Imaging Technology News magazine.

Fujifilm's first FDA-cleared computed tomography (CT) system, the FCT Embrace, at the American Society of Radiation Oncology (ASTRO) 2018 meeting in October. It is the world’s first 85 cm wide bore CT system. It offers 64 or 128 slice configurations.

With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry towards radiopharmaceuticals and in particular radiotherapeutics and radiotheranostics is clearly growing, as foreseen a few years ago by MEDraysintell.

Commercial developments this year reflect the rising profile of the patient in medical practice. Improvements in patient comfort have been direct contributors. Those involving efficiency and effectiveness have been indirect. The personalization of medicine factored in as well.

“The only constant in healthcare these days is change,” said Samantha E. Sizemore, chief operating officer/director of radiology at the Holston Medical Group (HMG), a physician-owned multi-specialty practice.

Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility. After all, they can’t fend for themselves, placing them among the most vulnerable patient populations. Perhaps equally vulnerable are adult patients who face one of the most harrowing health prospects — the possibility of losing a limb to amputation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now